Startups
Latest news, analysis, and updates on Startups from A47 News.
3 stories in Business · Updated live
Japan's Cabinet Approves Cryptocurrency Regulation as Financial Instruments
On April 10, 2026, Japan's Cabinet approved amendments to the Financial Instruments and Exchange Act to classify cryptocurrencies as financial products. This legislative shift is driven by the need to enhance investor protections and curb capital outflows to more favorable jurisdictions. Long-term, this reform is expected to legitimize digital assets in Japan, potentially attracting institutional investment and fostering market growth.
Alibaba Cloud Invests $293 Million in ShengShu Technology to Enhance AI Video Generation
Alibaba Cloud has led a $293 million funding round in Beijing-based AI startup ShengShu Technology, marking a significant investment in the AI video generation sector. This funding follows the recent reveal of Alibaba's HappyHorse 1.0 AI video model, which has gained top rankings in the industry. The long-term implication is a strengthened competitive position for ShengShu in China's AI market, particularly against rivals like ByteDance and Kuaishou, as they develop advanced multimodal AI capabilities.
Major Pharmaceutical Companies Secure Licensing Deals with Chinese Biotechs
Pfizer has entered an exclusive licensing agreement with China's 3SBio for a bispecific cancer antibody, marking a significant shift in Western pharmaceutical firms' reliance on Chinese biotech innovation. This trend is driven by the rapid development and lower costs associated with Chinese drug candidates, as evidenced by multiple licensing transactions totaling nearly $5.6 billion in 2025. In the long term, this could reshape the global pharmaceutical landscape, as Western companies increasingly prioritize partnerships with Chinese firms to replenish their drug pipelines amid patent expirations.
Latest Stories
Major Pharmaceutical Companies Secure Licensing Deals with Chinese Biotechs
Pfizer has entered an exclusive licensing agreement with China's 3SBio for a bispecific cancer antibody, marking a significant shift in Western pharmaceutical firms' reliance on Chinese biotech innovation. This trend is driven by the rapid development and lower costs associated with Chinese drug candidates, as evidenced by multiple licensing transactions totaling nearly $5.6 billion in 2025. In the long term, this could reshape the global pharmaceutical landscape, as Western companies increasingly prioritize partnerships with Chinese firms to replenish their drug pipelines amid patent expirations.
Japan's Cabinet Approves Cryptocurrency Regulation as Financial Instruments
On April 10, 2026, Japan's Cabinet approved amendments to the Financial Instruments and Exchange Act to classify cryptocurrencies as financial products. This legislative shift is driven by the need to enhance investor protections and curb capital outflows to more favorable jurisdictions. Long-term, this reform is expected to legitimize digital assets in Japan, potentially attracting institutional investment and fostering market growth.
Alibaba Cloud Invests $293 Million in ShengShu Technology to Enhance AI Video Generation
Alibaba Cloud has led a $293 million funding round in Beijing-based AI startup ShengShu Technology, marking a significant investment in the AI video generation sector. This funding follows the recent reveal of Alibaba's HappyHorse 1.0 AI video model, which has gained top rankings in the industry. The long-term implication is a strengthened competitive position for ShengShu in China's AI market, particularly against rivals like ByteDance and Kuaishou, as they develop advanced multimodal AI capabilities.